𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

✍ Scribed by Farina-Sarasqueta, A.; van Lijnschoten, G.; Moerland, E.; Creemers, G.- J.; Lemmens, V. E. P. P.; Rutten, H. J. T.; van den Brule, A. J. C.


Book ID
127313463
Publisher
Oxford University Press
Year
2010
Tongue
English
Weight
199 KB
Volume
21
Category
Article
ISSN
0923-7534

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Plasminogen activator inhibitor-1 is an
✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 103 KB πŸ‘ 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

Vascular endothelial growth factor, CD68
✍ Alok A. Khorana; Charlotte K. Ryan; Christopher Cox; Shirley Eberly; Deepak M. S πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 649 KB

## Abstract ## BACKGROUND The elucidation of new therapeutic targets of prognostic significance in colon carcinoma is necessary to improve outcomes. In the current study, the authors examined the expression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in